Response of Resistant Malignant Tumors to Neutron Therapy

Ludmila I. Musabaeva; Valery A. Lisin

doi:10.4028/www.scientific.net/AMR.1084.467

Paper Titles

Production of Meta-Iodobenzilguanidine, ¹²³I Preparation for Medical Diagnostics
p.451

Radiocardiopulmonography with ⁹⁹^mТс-Pertechnetate in the Study of Pulmonary and Myocardial Hemodynamics in Patients with Chronic Heart Failure
p.456

Radionuclide Diagnosis of Breast Cancers
p.460

Reactor Neutrons in Multimodality Treatment of Locally Advanced Breast Carcinoma
p.464

Response of Resistant Malignant Tumors to Neutron Therapy
p.467

Single-Photon Emission Computed Tomography and ^99mTc-Methoxy-Isobutyl-Isonitrile in the Detection and Forecast of Cardiotoxicity of Chemotherapeutic Agents
p.471

Single-Photon Emission Computed Tomography with ¹⁹⁹Tl in Diagnostics of Malignant Tumors of the Larynx and Laryngopharynx
p.476

SPECT with ^99mTc-HMPAO and Cognitive Function in Patients with Arterial Hypertension: Impact of Antihypertensive Therapy
p.479

Therapy of Malignant Tumor with 6.3 MeV Fast Neutrons
p.483

HomeAdvanced Materials ResearchAdvanced Materials Research Vol. 1084Response of Resistant Malignant Tumors to Neutron...

Response of Resistant Malignant Tumors to Neutron Therapy

Abstract:

Tumor response to 6.3 MeV fast neutrons generated by U-120 cyclotron was assessed. The study included: 26 patients with locally advanced breast cancer, who received neutron therapy in the regimen of high-dose daily fractions, followed by surgery; 41patients with head and neck cancer and 44 patients with musculoskeletal system cancer. The devised method of 6.3 MeV neutron therapy given in high-dose fractionation regimen resulted in complete tumor response compared to the standard photon therapy.